Breast Cancer Recurrent Clinical Trials
2 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 1
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Ovarian CancerAdvanced Solid TumorsBreast Cancer Recurrent+1 more
Accent Therapeutics90 enrolled5 locationsNCT06799065
Recruiting
Phase 2
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
Breast Cancer Recurrent
University of Utah80 enrolled1 locationNCT05464082
Recruiting
Not Applicable
Thermotherapy in Addition to SOC Palliative Radiotherapy
Head and Neck Squamous Cell CarcinomaCutaneous Squamous Cell CarcinomaBreast Cancer Recurrent
King's College London60 enrolled2 locationsNCT06659146
Recruiting
Not Applicable
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Breast CancerBreast Cancer Recurrent
University Health Network, Toronto171 enrolled15 locationsNCT05592938
Recruiting
Phase 2
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
Breast Cancer Recurrent
Min Yan, MD40 enrolled1 locationNCT06458413
Recruiting
Not Applicable
18F-FDG PET/CT Imaging for Breast Cancer
Breast Cancer FemaleBreast Cancer Recurrent
Vestre Viken Hospital Trust300 enrolled1 locationNCT05730608